Total investments

7

Average round size

11M

Portfolio companies

6

Rounds per year

0.39

Lead investments

1

Follow on index

0.14

Exits

2

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceSoftwareInformation TechnologyHealth CareSaaSEnterprise SoftwareCloud ComputingTherapeuticsHardware

Summary

Working Opportunity Fund is the famous VC, which was founded in 2003. The venture was found in North America in Canada. The leading representative office of defined VC is situated in the Vancouver.

Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. This Working Opportunity Fund works on 0 percentage points less the average amount of lead investments comparing to the other organizations. The top activity for fund was in 2003. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2015. The fund is generally included in less than 2 deals every year.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Canada. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline MSI Methylation Sciences, AppNeta, Teradici Among the most popular fund investment industries, there are Business Intelligence, Health Care. The fund has exact preference in a number of founders of portfolio startups.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Working Opportunity Fund, startups are often financed by Skypoint Capital, GrowthWorks Capital, Alta Berkeley Venture Partners. The meaningful sponsors for the fund in investment in the same round are Yaletown Partners, Ventures West, TELUS Ventures. In the next rounds fund is usually obtained by Yaletown Partners, OVP Venture Partners, GrowthWorks Capital.

Show more

Investments analytics

Analytics

Total investments
7
Lead investments
1
Exits
2
Rounds per year
0.39
Follow on index
0.14
Investments by industry
  • Software (4)
  • Biotechnology (3)
  • Health Care (2)
  • Therapeutics (2)
  • Enterprise Software (2)
  • Show 9 more
Investments by region
  • Canada (5)
  • United States (2)
Peak activity year
2003

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Group Appearance index
1.00
Avg. company exit year
13

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
MSI Methylation Sciences 29 Sep 2011 Biotechnology, Medical, Therapeutics, Dietary Supplements Early Stage Venture 15M British Columbia, Burnaby, Canada

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.